Trilogy Capital’s Strive Total Return Bond ETF STXT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$313K Buy
16,509
+1,111
+7% +$21.6K 0.01% 335
2026
Q2
$302K Buy
15,398
+30
+0.2% +$596 0.01% 330
2026
Q1
$306K Buy
15,368
+2,154
+16% +$43.3K 0.01% 315
2025
Q4
$266K Buy
13,214
+42
+0.3% +$851 0.01% 334
2025
Q3
$267K Buy
13,172
+28
+0.2% +$566 0.01% 332
2025
Q2
$265K Buy
13,144
+36
+0.3% +$720 0.01% 312
2025
Q1
$264K Buy
13,108
+1,582
+14% +$31.6K 0.01% 299
2024
Q4
$228K Buy
+11,526
New +$232K 0.01% 308

Other funds holding STXT

Trilogy Capital's STXT Position: Q3 2026 in Review

Trilogy Capital increased its Strive Total Return Bond ETF (STXT) stake by 7.2% in Q3 2026, buying an estimated $21.6K and bringing the position to 16,509 shares worth $313K. The position accounts for 0.01% of the portfolio, ranked #335.

Trilogy Capital first reported a position in STXT in Q4 2024 and has held it in 8 quarters since. 5 funds tracked by Wall St. Rank hold STXT as of Q3 2026.

  • Trilogy Capital held 16,509 shares of Strive Total Return Bond ETF worth $313K as of Q3 2026.
  • Trilogy Capital bought 1,111 Strive Total Return Bond ETF shares in Q3 2026, an estimated $21.6K.
  • Strive Total Return Bond ETF made up 0.01% of Trilogy Capital's portfolio in Q3 2026, its #335 holding.
  • Trilogy Capital first reported a position in Strive Total Return Bond ETF in Q4 2024 and has held it in 8 quarters since.
  • 5 funds tracked by Wall St. Rank held Strive Total Return Bond ETF as of Q3 2026.

Based on Trilogy Capital's 13F filing for Q3 2026, filed 20 Oct 2026.